MARAVAI LIFESCIENCES HLDGS-A (MRVI) Stock Analyst Ratings
NASDAQ:MRVI - Nasdaq - US56600D1072 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 78% to MRVI. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 9.52. This target is 121.3% above the current price.
MRVI was analyzed by 22 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about MRVI.
In the previous month the buy percentage consensus was at a similar level.
MRVI was analyzed by 22 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-12-05 | Goldman Sachs | Downgrade | Neutral -> Sell |
| 2024-11-14 | Wolfe Research | Initiate | Peer Perform |
| 2024-11-08 | William Blair | Downgrade | Outperform -> Market Perform |
| 2024-11-08 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-11-08 | Baird | Maintains | Outperform -> Outperform |
| 2024-10-08 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2024-08-27 | Wells Fargo | Initiate | Overweight |
| 2024-08-16 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-08-13 | Morgan Stanley | Downgrade | Overweight -> Equal-Weight |
| 2024-08-08 | UBS | Maintains | Neutral -> Neutral |
| 2024-08-08 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2024-07-09 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2024-05-09 | Baird | Maintains | Outperform -> Outperform |
| 2024-04-10 | Craig-Hallum | Initiate | Buy |
| 2024-02-23 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-02-23 | Stifel | Maintains | Buy -> Buy |
| 2023-12-12 | B of A Securities | Upgrade | Neutral -> Buy |
| 2023-11-09 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2023-11-09 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2023-08-09 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2023-08-08 | Deutsche Bank | Maintains | Buy -> Buy |
| 2023-08-08 | Keybanc | Downgrade | Overweight -> Sector Weight |
| 2023-08-08 | RBC Capital | Maintains | Outperform -> Outperform |
| 2023-08-08 | Baird | Maintains | Outperform -> Outperform |
| 2023-08-08 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2023-08-08 | Credit Suisse | Maintains | Neutral -> Neutral |
| 2023-05-23 | Credit Suisse | Downgrade | Outperform -> Neutral |
| 2023-05-10 | Goldman Sachs | Maintains | Neutral |
| 2023-05-10 | Morgan Stanley | Maintains | Overweight |
| 2023-05-09 | Deutsche Bank | Maintains | Buy |